His primary areas of study are Drug delivery, Nanoparticle, Nanotechnology, Biocompatibility and Biophysics. His Drug delivery study incorporates themes from Click chemistry, Surface modification, Biodistribution, Permeation and Mucoadhesion. His Nanoparticle research is multidisciplinary, incorporating perspectives in Porous silicon and Stereochemistry.
In his study, Microfluidics, Dispersity and Extrusion is inextricably linked to Polymer, which falls within the broad field of Nanotechnology. His biological study spans a wide range of topics, including Combination chemotherapy and In vitro. His Biophysics research includes themes of Chitosan, Membrane and Drug carrier.
Ermei Mäkilä mostly deals with Drug delivery, Nanotechnology, Nanoparticle, Porous silicon and Biocompatibility. His work deals with themes such as Controlled release, Biophysics, Surface modification and Biomedical engineering, which intersect with Drug delivery. The study incorporates disciplines such as Cell, Insulin and Permeation in addition to Biophysics.
The concepts of his Nanotechnology study are interwoven with issues in Chitosan, Cancer cell and Polymer. His Nanoparticle research integrates issues from Conjugated system, In vitro, Biodistribution and Undecylenic acid. His Porous silicon research includes elements of Carbonization and Dextran.
His primary scientific interests are in Nanoparticle, Porous silicon, Drug delivery, Nanotechnology and Biophysics. His biological study spans a wide range of topics, including Biomaterial and Cell biology. The study incorporates disciplines such as Characterization, Spice, Carbonization and Cell membrane in addition to Porous silicon.
The various areas that Ermei Mäkilä examines in his Drug delivery study include Drug, Biocompatibility, Doxorubicin, Endocytosis and Biomedical engineering. His study in the field of Colloidal gold and Photothermal therapy also crosses realms of Glial cell line-derived neurotrophic factor and Parkinson's disease. His Biophysics research incorporates elements of Cell, Controlled release, Insulin, Transcytosis and Nanomedicine.
The scientist’s investigation covers issues in Drug delivery, Nanoparticle, Nanotechnology, Drug and Porous silicon. His Drug delivery research is multidisciplinary, incorporating perspectives in Microfluidics, Doxorubicin, Fc receptor, Transcytosis and Nanomedicine. His Nanoparticle research includes elements of Biophysics, Insulin and Controlled release.
His work carried out in the field of Nanotechnology brings together such families of science as Chitosan and Dextran. His work deals with themes such as In vitro model, Gastrointestinal tract and Nanocomposite, which intersect with Drug. His Porous silicon study integrates concerns from other disciplines, such as Characterization, Carbonization, Optical sensing and Surface modification.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
Luis M. Bimbo;Mirkka Sarparanta;Hélder A. Santos;Anu J. Airaksinen.
ACS Nano (2010)
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size.
Hélder A. Santos;Joakim Riikonen;Jarno Salonen;Ermei Mäkilä.
Acta Biomaterialia (2010)
Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices.
Natalja Genina;Jenny Holländer;Harri Jukarainen;Ermei Mäkilä.
European Journal of Pharmaceutical Sciences (2016)
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
Luis M. Bimbo;Ermei Mäkilä;Timo Laaksonen;Vesa-Pekka Lehto.
The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
Mohammad-Ali Shahbazi;Mehrdad Hamidi;Ermei M. Mäkilä;Ermei M. Mäkilä;Hongbo Zhang.
Drug Delivery Formulations of Ordered and Nonordered Mesoporous Silica: Comparison of Three Drug Loading Methods
Tarja Limnell;Hélder A. Santos;Ermei Mäkilä;Teemu Heikkilä.
Journal of Pharmaceutical Sciences (2011)
Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.
Hélder A. Santos;Ermei Mäkilä;Anu Airaksinen;Luis Maria Bimbo.
Nanomedicine: Nanotechnology, Biology and Medicine (2014)
Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
Dongfei Liu;Luis M. Bimbo;Ermei Mäkilä;Francesca Villanova;Francesca Villanova.
Journal of Controlled Release (2013)
Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Päivi Kinnari;Ermei Mäkilä;Teemu Heikkilä;Jarno Salonen.
International Journal of Pharmaceutics (2011)
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution
Mirkka Sarparanta;Luis M. Bimbo;Jussi Rytkönen;Ermei Mäkilä.
Molecular Pharmaceutics (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: